SALZBURG, Austria & GHENT, Belgium–(BUSINESS WIRE)– MyCartis, the provider of fully integrated and broadly applicable molecular diagnostics and immunodiagnostics solutions, and Sony DADC BioSciences today announced the cooperation in the production of a microfluidic assay cartridge for MyCartis’ Evalution^TM digital multiplex analysis platform to support a range of applications in the clinical research and pharmaceutical markets and designed to analyze a broad range of protein and nucleic acid-based biomarkers.

Sony DADC BioSciences, a leading supplier of smart polymer parts for the biomedical industry, is using their ISO 13485-certified facility in Salzburg, Austria for manufacturing. The customized foil bonded cartridge is manufactured as a monolithic molded microtiter size plate that has optical transparency and combines macrostructures, high precision microstructures and filter structures for achieving the ultra-sensitivity of the Evalution^TM System.

“We are very pleased to be working with Sony DADC BioSciences as our development and manufacturing partner for the Evalution^TM cartridge. The collaboration between the two companies brings together a broad range of knowledge and experience, which are important for the success of innovative new technologies such as the Evalution^TM System,” said Joris Schuurmans, CEO of MyCartis.

The highly integrated assay cartridge contains reaction and detection chambers to ensure short time to result and minimal processing steps. Next to the ability to run 1 to 16 samples at the same time the Evalution^TM System further delivers superior data quality and rapid results.

“We are fascinated about MyCartis’ flexible Evalution^TM platform and enjoy our mutual team spirit. From a manufacturing perspective, the project enhances our capabilities in both injection molding and bonding of microfluidic consumables in micro titer plate format – the de facto industry standard,” said Werner Balika, Engineering Manager at Sony DADC BioSciences GmbH.

About MyCartis

MyCartis’ innovative research and diagnostic system, called Evalution^TM, features the measurement and detection of molecular components of different nature (proteins, nucleic acids…), indicative of a specific pathological state in a multiplex format. The new semi-automated system is highly user-friendly thanks to its integrated workflow and provides rapid and robust results thanks to improved kinetics in the microfluidic channels. In addition, MyCartis develops ready-to-use multiplex assays with major clinical and compelling health economic values, through its own development efforts as well as through strategic partnerships. Oncology, neurology, cardiology and immunology are MyCartis’ primary focus.

For more information please visit http://www.mycartis.net/

About Sony DADC BioSciences GmbH

Building on Sony DADC’s experience in high-precision optical disc manufacturing, Sony DADC BioSciences partners with Life Sciences and Diagnostics companies enabling the industrial manufacturing of smart polymer parts.

For more information please visit http://biosciences.sonydadc.com